$0.5505
-0.00244-0.44%
Pre-Market: Mar 24, 6:35 PM EDT
Comments
Loading...
Entero Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ENTO | Benzinga
Entero Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-0.590
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Entero Therapeutics using advanced sorting and filters.
Entero Therapeutics (ENTO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-13 | $-0.59 | $-0.32 | -84.4 % |
| Q2 | 2024-10-21 | $-3.86 | $-0.32 | -1106.3 % |
Entero Therapeutics (ENTO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Entero Therapeutics (NASDAQ:ENTO) reporting earnings?
Entero Therapeutics (ENTO) is scheduled to report earnings on May 20, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Entero Therapeutics (NASDAQ:ENTO)?
The Actual EPS was $-0.59, which missed the estimate of $-0.32.
What were Entero Therapeutics’s (NASDAQ:ENTO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.